The Japan Single Cell Analysis Market was valued at $167.9 Million in 2025 and projected to reach to $368.7 Million by 2030, representing a compound annual growth rate of 17.0%. Japan's single cell analysis market is poised for significant expansion, driven by technological advancement and increasing adoption across research and clinical settings.
Japan's single cell analysis market is valued at $167.9 million in 2025, with a projected CAGR of 17% through 2030, reaching $368.7 million. This growth rate exceeds the global average of 14.7%, positioning Japan as a high-growth market in the Asia-Pacific region.
Japan's robust genomic research ecosystem, supported by leading universities and research institutions, is driving widespread adoption of single cell analysis technologies. Strong government funding and collaboration between academia and industry accelerate innovation and market penetration.
Japanese pharmaceutical companies and diagnostic laboratories are increasingly integrating single cell analysis into drug discovery, development, and precision diagnostics. This adoption supports personalized medicine initiatives and enhances therapeutic efficacy across oncology, immunology, and regenerative medicine sectors.
Japan's strategic focus on precision medicine and genomic healthcare creates sustained demand for single cell analysis technologies. Government initiatives and healthcare modernization efforts position the country as a key market for advanced cellular analysis solutions.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ACADEMIC & RESEARCH LABORATORIES (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 14.7% from 2025 to 2030 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 3.81 (2025) |
| Revenue Forecast (Billions) | ~USD 7.56 (2030) |
| Segments Covered | Application, Type, Cell Type, End User, Product |
5 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PATHEON INC | Netherlands | Private Company | Drug product services (finished dosage manufacturing and packaging),Pharmaceutical development services,Drug substance services (API and biologics), |
| ABCAM PLC | United Kingdom | Private Company | Primary antibodies,Secondary and conjugated antibodies,Immunoassays (singleplex) and kits, |
| BECKMAN COULTER | United States | Private Company | Clinical diagnostics (chemistry, hematology, immunoassay, urinalysis, blood banking, hemostasis, integrated systems),Life science research and discovery (flow cytometry, genomic and protein analysis, liquid handling, research automation),Industrial and particle characterization (coulter counters, particle size, zeta potential, electrochemistry), |
| DECODE GENETICS | Iceland | Private Company | Internal genomics support for Amgen R&D,External research collaborations and consortia,Genome sequencing and analytical services, |
| BD | United States | Public Company | Medical Essentials (syringes, needles, IV catheters, sharps, basic disposables),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems and related services), |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing, single-use, media, filtration, aseptic fill-finish),Life Sciences (instruments, genomics, proteomics, imaging, lab automation),Diagnostics (clinical instruments, consumables, software, services), |
| 10X GENOMICS | United States | Public Company | Chromium instruments,Chromium consumables & QuantumScale kits,Visium spatial platform (instruments, slides, reagents), |
| MERCK KGAA | Germany | Public Company | Life Science (tools, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, gases, equipment), |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| QIAGEN | Netherlands | Public Company | Sample technology consumables and instruments,PCR and digital PCR (research and clinical),Molecular diagnostics assays (TB, oncology, SRH, transplant, viral load), |
| ILLUMINA, INC. | United States | Public Company | Sequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based instruments and consumables, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Instruments and Systems,Life Science Reagents and Consumables, |
| DIASORIN S.P.A. | Italy | Public Company | LIAISON XL / LIAISON XS immunodiagnostics,Molecular diagnostics (Simplexa, LIAISON PLEX assays),xMAP technology and other IVD solutions, |
| STANDARD BIOTOOLS | United States | Public Company | Proteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and legacy genomics),Services, software, and other, |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, filtration, chromatography, fluid management),Lab products and services (weighing, pipetting, filtration, water systems, microbiological testing),Analytical solutions (BLI, cytometry, live-cell imaging, SPR, PAT and data analytics), |
| CORNING INCORPORATED | United States | Public Company | Optical communications (fiber, cable, connectivity, hardware),Display glass substrates (LCD and OLED),Specialty materials and mobile consumer electronics glass, |
| CYTEK BIOSCIENCES | United States | Public Company | Aurora / Aurora Evo / Aurora CS spectral systems,Northern Lights and mid-range flow cytometers,Amnis imaging flow cytometers, |
Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.
Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees specializing in life science research products.
Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees manufacturing laboratory instruments and diagnostics.
Decode Genetics is an Iceland-based private company founded in 1996 with 331 employees focused on genetic research and analysis.
BD is a United States-based public company founded in 1897 with 72,000 employees manufacturing medical devices, diagnostics, and life science tools.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees providing laboratory equipment, reagents, and services.
Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees operating diversified businesses including life sciences and diagnostics.
10X Genomics is a United States-based public company founded in 2012 with 1,178 employees developing single-cell and spatial genomics solutions.
Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating in pharmaceuticals, life sciences, and performance materials.
Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees manufacturing analytical instruments and life science tools.
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and sample preparation solutions.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees developing DNA sequencing and genetic analysis technologies.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees manufacturing life science research and clinical diagnostics products.
DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees specializing in in vitro diagnostics and immunoassay systems.
Standard Biotools is a United States-based public company founded in 1999 with 387 employees developing microfluidics and single-cell analysis platforms.
Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees providing laboratory and bioprocess equipment and services.
Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass, ceramics, and life science products.
Cytek Biosciences is a United States-based public company founded in 1992 with 678 employees developing flow cytometry and cell analysis technologies.
Japan's single cell analysis market is valued at $167.9 million in 2025 and is projected to grow to $368.7 million by 2030.
Japan's single cell analysis market is growing at a compound annual growth rate (CAGR) of 17.0% from 2025 to 2030.
Japan's growth is driven by advanced research infrastructure, precision medicine initiatives, an aging population requiring personalized healthcare, and strong government support for biotechnology innovation.
Single cell analysis is being adopted across Japan's academic institutions, pharmaceutical companies, diagnostic laboratories, and clinical research centers for both research and diagnostic applications.
Japan is positioned as a leading market in Asia Pacific due to its advanced research infrastructure, strong biotechnology sector, and commitment to precision medicine and cellular-level research.
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-cell analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), and Society for Laboratory Automation and Screening (SLAS), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell analysis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks, and IVF centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Single-cell analysis is a method for examining individual cells across various parameters, particularly beneficial when dealing with diverse cell populations. This approach focuses on studying a single cell isolated from tissues in a multicellular organism. Technologies including flow cytometry and microfluidics are used for single-cell analysis purpose. Such analysis facilitates the exploration of variations between cells within a population. Currently, single-cell analysis finds extensive applications in cancer research, immunology, stem cell research, and neurobiology.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Full forecast, segment splits, and company analysis for all Single Cell Analysis Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report